Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-24 @ 5:30 PM
Study NCT ID:
NCT06807268
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-01-29
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-29
First Submit QC Date:
None
Study First Post Date:
2025-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED